Gilder Gagnon Howe & CO LLC Nevro Corp Transaction History

Gilder Gagnon Howe & CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$81.07 - $121.29 $813,618 - $1.22 Million	-10,036 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $25,089 - $40,924	246 Added 2.51%	10,036 $1.17 Million
Q2 2021 Aug 16, 2021	BUY	$141.6 - $179.06 $7,363 - $9,311	52 Added 0.53%	9,790 $1.62 Million
Q1 2021 May 17, 2021	BUY	$132.81 - $182.18 $48,874 - $67,042	368 Added 3.93%	9,738 $1.36 Million
Q4 2020 Feb 16, 2021	BUY	$138.17 - $184.34 $1.29 Million - $1.73 Million	9,370 New	9,370 $1.62 Million
Q4 2017 Jan 31, 2018	SELL	$65.94 - $93.31 $81,304 - $115,051	-1,233 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$80.87 - $91.08 $99,712 - $112,301	1,233	1,233 $112,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $140M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.